Concepedia

Palifermin Therapy

Palifermin Therapy is a recombinant human keratinocyte growth factor-based pharmacological intervention classified as a biologic response modifier, distinguished by its specific indication for reducing the incidence and duration of severe oral mucositis in hematologic malignancy patients undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation.

74

Publications

5.1K

Citations

441

Authors

200

Institutions

Publications per year

2017–2026

2

Parents

Publications

74

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

Ricardo Spielberger, Patrick J. Stiff, William Bensinger et al. · New England Journal of Medicine · 2004 · 901 citations

, , +15

Updated clinical practice guidelines for the prevention and treatment of mucositis

Dorothy Keefe, Mark M. Schubert, Linda S. Elting et al. · Cancer · 2007 · 784 citations

, , +17

NCCN Task Force Report: Prevention and Management of Mucositis in Cancer Care

William Bensinger, Mark Schubert, Kie-Kian Ang et al. · Journal of the National Comprehensive Cancer Network · 2008 · 242 citations · Full text

, , +15

Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study

Quynh‐Thu Le, Harold E. Kim, Charles Schneider et al. · Journal of Clinical Oncology · 2011 · 186 citations

, , +15

Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.

Sol Silverman · PubMed · 2007 · 180 citations

, , +17

1–5 of 74

Authors

441

  1. RS
    Ricardo Spielberger

    City Of Hope National Medical Center, United States

    6 publications · 1.4K citations

    6

    h-index

  2. WD
    Wolfgang Dörr

    University Hospital Carl Gustav Carus, Germany

    5 publications · 138 citations

    5

    h-index

  3. PJ
    Patrick J. Stiff

    Loyola University Medical Center, United States

    5 publications · 1.1K citations

    5

    h-index

  4. BR
    Bruce R. Blazar

    University of Minnesota, United States

    4 publications · 1.1K citations

    4

    h-index

  5. DB
    Dietmar Berger

    University of Freiburg, Germany

    4 publications · 472 citations

    4

    h-index

1–5 of 441

Institutions

200

  1. Amgen (United States)

    Thousand Oaks, United States

    11 h-index

    48 publications

    5.4K citations

  2. Swedish Orphan Biovitrum (Sweden)

    Stockholm, Sweden

    5 h-index

    14 publications

    270 citations

  3. University Hospital Carl Gustav Carus

    Dresden, Germany

    5 h-index

    9 publications

    336 citations

  4. Radboud University Nijmegen

    Nijmegen, The Netherlands

    4 h-index

    10 publications

    240 citations

  5. City Of Hope National Medical Center

    Duarte, United States

    4 h-index

    19 publications

    2.6K citations

  6. Radboud University Medical Center

    Nijmegen, The Netherlands

    4 h-index

    10 publications

    240 citations

  7. The University of Texas MD Anderson Cancer Center

    Houston, United States

    4 h-index

    8 publications

    2K citations

  8. University of Minnesota

    Minneapolis, United States

    4 h-index

    16 publications

    3.1K citations

1–8 of 200

Venues

  1. PubMed

    Repository · 8 publications · 455 citations

    8

    h-index

  2. Biology of Blood and Marrow Transplantation

    TCT · 7 publications · 222 citations

    7

    h-index

  3. Bone Marrow Transplantation

    7 publications · 278 citations

    7

    h-index

  4. Journal of Clinical Oncology

    5 publications · 716 citations

    5

    h-index

  5. International Journal of Radiation Biology

    3 publications · 72 citations

    3

    h-index

1–5